4.7 Article

Epigenetics and Epigenomics: Implications for Diabetes and Obesity

Journal

DIABETES
Volume 67, Issue 10, Pages 1923-1931

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/db18-0537

Keywords

-

Funding

  1. National Institutes of Health
  2. JDRF
  3. Lilly
  4. Boehringer Ingelheim
  5. GSK
  6. Regeneron
  7. Merck
  8. ONO Pharma
  9. Celgene

Ask authors/readers for more resources

The American Diabetes Association convened a research symposium, Epigenetics and Epigenomics: Implications for Diabetes and Obesity on 17-19 November 2017. International experts in genetics, epigenetics, computational biology, and physiology discussed the current state of understanding of the relationships between genetics, epigenetics, and environment in diabetes and examined existing evidence for the role of epigenetic factors in regulating metabolism and the risk of diabetes and its complications. The authors summarize the presentations, which highlight how the complex interactions between genes and environment may in part be mediated through epigenetic changes and how information about nutritional and other environmental stimuli can be transmitted to the next generation. In addition, the authors present expert consensus on knowledge gaps and research recommendations for the field.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available